Jessa Boubker is a health care lawyer with Foley & Lardner LLP and a member of the firm’s Health Care Practice Group. Jessa’s practice focuses on a broad range of federal and state regulatory compliance, transactional, and business matters for health industry clients, including hospitals, health systems, provider practice groups, long-term care facilities, and medical device companies.
Jessa has assisted in the development and maintenance of clinical trial compliance programs, and has drafted and reviewed clinical trial agreements and corporate policies on behalf of institutions, contract research organizations, and pharmaceutical and medical device clients. She has worked with a number of digital health companies to launch and scale their direct-to-consumer telehealth platforms and operations throughout the United States, and has helped advise clients on regulatory compliance considerations when developing software as a medical device, including devices employing artificial intelligence. Jessa is a member of the American Telemedicine Association, serving on the ATA’s Therapeutic Lifecycle, Healthy Aging, and Digital Transformation special interest groups.
Prior to joining Foley, Jessa was the Editor-in-Chief of the American Journal of Law & Medicine, the country’s leading health law journal. During her time as Editor-in-Chief, she published four issues of the journal and oversaw the 2021 Annual Symposium: Legal Innovations in Response to Public Health Crises. She also developed and published a special issue of the journal: Diversity and Inclusion in the American Legal Profession: Discrimination and Bias Reported by Lawyers with Disabilities and Lawyers Who Identify as LGBTQ+.
While in law school, Jessa served as a judicial intern for Magistrate Judge Donald L. Cabell of the U.S. District Court for the District of Massachusetts. She was also a member of the Legislative Policy & Drafting Clinic and drafted long-term care legislation on behalf of a Massachusetts State Senator. Jessa began her career as a summer associate at Foley, where she assisted on a range of regulatory and transactional matters.
More Legal and Business Bylines From Jessa Boubker
- Clinical Trials: FDA Issues Finalized Charging Guidance for Investigational Drug Use - (Posted On Wednesday, March 13, 2024)
- OIG Opines on Subsidizing Medicare Cost-Sharing for Clinical Trials - (Posted On Monday, February 26, 2024)
- Decentralized Clinical Trials: Diversity in Clinical Trials - (Posted On Wednesday, December 06, 2023)
- Clinical Trials: Consent Process Clarified in New FDA Final Guidance - (Posted On Friday, September 08, 2023)
- Decentralized Clinical Trials Blog Series - (Posted On Monday, June 26, 2023)
- Software as a Medical Device: Challenges Facing the Industry - (Posted On Tuesday, May 16, 2023)
- FDA’s New Guidance Proposes Flexible Use of AI in Medical Devices - (Posted On Wednesday, May 10, 2023)
- FDA Encourages the Use of Decentralized Clinical Trials in New Draft Guidance - (Posted On Friday, May 05, 2023)
- Migraine Company Fails to Avoid Own Headache: Jet Medical and Others to Pay $745,000 to Resolve Allegations that Medical Device was not Approved or Cleared before Commercialization - (Posted On Wednesday, January 11, 2023)
- FDA Addresses the Role of Digital Health Technology in Clinical Trials - (Posted On Tuesday, January 11, 2022)